Artialis Overview

  • Founded
  • 2010
  • Status
  • Private
  • Employees
  • 19
  • Latest Deal Type
  • Bankr. Admin/​Reorg

Artialis General Information


Developer of biomarkers and drug candidates designed to treat musculoskeletal disorders such as osteoarthritis and rheumatoid arthritis. The company's biomarkers and drug candidate-based immunoassays and trials are used for the diagnosis, the prognosis and the follow-up of musculoskeletal disorders, enabling the joint health market to improve joint comfort and bridge the gap between joint disorders and effective treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Diagnostic Equipment
Laboratory Services (Healthcare)
Other Pharmaceuticals and Biotechnology
Primary Office
  • Avenue de l'Hôpital, 11
  • Tour GIGA B34 (+3)
  • 4000 Liège
  • Belgium
+32 04 000 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Artialis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Bankruptcy: Admin/Reorg 05-Feb-2020 Completed Bankruptcy: Admin/Reorg
3. Early Stage VC 00.000 00.000 Completed Generating Revenue
2. Accelerator/Incubator $654K Completed Generating Revenue
1. Debt - General $654K $654K Completed Startup
To view Artialis’s complete valuation and funding history, request access »

Artialis Executive Team (9)

Name Title Board Seat Contact Info
Yves Henrotin Ph.D Founder, Executive President & Chairman
Bérénice Costes Co-CRO & Chief Operating Officer
Anne-Christine Hick Chief Scientific Officer
Christelle Boileau Executive Officer
You’re viewing 4 of 9 executive team members. Get the full list »

Artialis Board Members (2)

Name Representing Role Since
Pampfer Serge Ph.D WBC Ventures Board Member 000 0000
Yves Henrotin Ph.D Artialis Founder, Executive President & Chairman 000 0000
To view Artialis’s complete board members history, request access »

Artialis Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial